Data center REITs drove the S&P 500 real estate sector (XLRE) lower this week amid the rise of the Chinese AI startup ...
Shares of weight-loss drug developer Metsera jumped nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture ...
AbbVie's acquisition of Allergan significantly increased the firm's debt level. We expect the firm's net debt position to peak at close to $70 billion in 2020 but given the strong cash flows of AbbVie ...
The IPO comes amid a deregulatory push in the energy sector by President Donald Trump, who repeated the "drill, baby, drill" slogan in his inaugural address. Earlier this week, Sean Duffy, the newly ...
Barclays lowered the firm’s price target on XPLR Infrastructure (NEP) to $7 from $17 and keeps an Underweight rating on the shares. The firm ...
H.C. Wainwright analyst Ed Arce maintained a Buy rating on Inventiva (IVA – Research Report) yesterday and set a price target of $13.00.Invest ...
BofA has maintained BUY rating on Reliance Industries Limited (RIL) shares. It said that risk-reward is favourable in Reliance Industries shares and catalysts key for re-rating.
Infinera's declining revenue, high debt, and reliance on a few key customers make it an unattractive investment. Learn why ...
Capital market regulator Sebi rejected the competing open offer made by the US-based entity Danny Gaekwad Developments & ...
NextEra's stock fell 4.5% to close at $70.54 after XPLR, which is majority owned by NextEra Energy and designed to acquire clean-energy projects for the company, hit a record-low stock price, ending ...
Capital market regulator Sebi on Tuesday rejected the competing open offer made by the US-based entity Danny Gaekwad ...
Sebi rejected a competing open offer by Danny Gaekwad Developments & Investments to acquire Religare Enterprises Ltd (REL) ...